Medical News

RSS

Third-quarter 2009 financial results of Antigenics announced

Antigenics Inc. reported today its results for the quarter ended September 30, 2009. The company incurred a net loss attributable to common stockholders of $10.8 million, or $0.13 per share, basic and diluted, for the third quarter of 2009, compared with a net loss attributable to common stockholders in the third quarter of 2008 of $11.4 million, or $0.17 per share, basic and diluted.

29 Oct 2009

Gentiva Health Services reports decreased net revenues for 2009 third quarter

Gentiva Health Services, Inc. (Nasdaq: GTIV), a leading provider of comprehensive home health services, today reported the following 2009 third quarter results.

29 Oct 2009

Third-quarter fiscal 2009 results announced by Medifast

Medifast, Inc., a provider of leading clinically proven portion-controlled weight-loss programs, announced today third quarter financial results for the period ended September 30, 2009.

29 Oct 2009

Neogenomics declares third quarter 2009 financial results; significantly improved liquidity position

NeoGenomics, Inc. (OTC Bulletin Board: NGNM), a leading provider of cancer-focused genetic testing services today reported its results for the third quarter of 2009.

29 Oct 2009

Encision announces financial results for its second quarter of fiscal year 2010

Encision Inc., a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, reported its financial results for its second quarter of fiscal year 2010.

29 Oct 2009

BioCryst Pharmaceuticals reports fiscal 2009 third-quarter results

BioCryst Pharmaceuticals, Inc. announced financial results for the quarter and nine months ended September 30, 2009 and provided a corporate update regarding clinical programs and potential emergency use of intravenous (i.v.) peramivir.

29 Oct 2009

EB Sport announces the availability two branded fitness kits for men and women

EB Sport Group, a market leader in the creation of personal exercise and fitness products, has announced the availability of the Men’s Health “Ultimate Total-Body Workout” and Women’s Health “Lean Body Workout” – two branded fitness kits designed to get people back in shape quickly.

29 Oct 2009

Third quarter 2009 financial results announced by United Therapeutics

United Therapeutics Corporation (Nasdaq: UTHR) today announced its results of operations for the quarter ended September 30, 2009.

29 Oct 2009

Bruker Corporation revenue increases by 9.5% in third-quarter 2009

Bruker Corporation today reported financial results for the third quarter ended September 30, 2009.

29 Oct 2009

First Edition: October 29, 2009

Today's headlines are all about the unveiling of the House health bill -- expected later this morning.

29 Oct 2009

Third-quarter fiscal 2009 results announced by Curis

Curis, Inc., a drug development company seeking to develop proprietary targeted medicines for cancer treatment, today reported its financial results for the third quarter ended September 30, 2009.

29 Oct 2009

Seminar on multiple myeloma

MediCom Worldwide, Inc., an accredited provider of continuing medical education for physicians, pharmacists, and nurses, announces a Friday Satellite Symposium on Multiple Myeloma Preceding the 51st ASH Annual Meeting entitled Unifying Practice Patterns Among Academic and Community Clinicians: Focus on Myeloma.

29 Oct 2009

Publix Supermarkets to sell HeartSavior and LipidShield Plus

New Health Corp. is proud to announce that HeartSavior(TM) and LipidShield® Plus are now available at Publix Supermarkets.

29 Oct 2009

Mylan reports total revenues of $3.74 billion for the nine months ended September 30, 2009

Mylan Inc. today announced its financial results for the three and nine months ended September 30, 2009.

29 Oct 2009

Genetic mutations may put individuals at increased risk for fungal infections

New research has identified two genetic mutations that may put individuals at increased risk for fungal infections. The research focused on patients with severe fungal infections (primarily of the genus Candida), but the findings may also have implications for patients who have more common mild infections.

29 Oct 2009

Tool to support the development of age-based dosing regimens for malaria drugs developed

Scientists at LSTM have developed a tool to support the development of appropriate age-based dosing regimens for malaria drugs. Weight-based dosing is challenging in many malaria endemic countries because access to formal health services is limited, functioning scales may be scarce and many treatments are given at home using antimalarials bought from shops and street vendors.

29 Oct 2009

HealthSpring's net income up by $42.3 million in the third-quarter of 2009

HealthSpring, Inc. today announced its results for the third quarter and nine months ended September 30, 2009.

29 Oct 2009

Grassroots Health and the University of Toronto School of Medicine to host a Vitamin D symposium

Vitamin D Deficiency - linked to significantly higher rates of most cancers, heart disease, autoimmune diseases such as multiple sclerosis, and even flu - affects 97 per cent of Canadians. Yet fewer than 3 per cent of Canadians say they know their vitamin D blood levels.

29 Oct 2009

Non-surgical alternative treatment for moderate to advanced gum disease announced

BIOLASE Technology, Inc. today announced its new Deep Pocket Therapy with New Attachment™ using the Waterlase MD™ and patented Radial Firing Perio Tips™ (RFPT) for a non-surgical alternative treatment for moderate to advanced gum disease.

29 Oct 2009

iVolution Medical Systems to launch a loan program that offers physicians easy access to working capital

Universal Capital Management, Inc., a Wilmington, Delaware business development company that provides management and strategic growth resources to emerging growth companies, is pleased to announce that one of its holdings, iVolution Medical Systems, Inc., is preparing to launch a loan program that offers physicians easy access to working capital.

29 Oct 2009